FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma - Dhir, M; Zenati, M S; Hamad, A (Ann Surg Oncol, 2018)
et al.